Quita Highsmith is vice president and chief diversity officer at Genentech. From the San Francisco ... What's more, the company said it would spend $1 billion annually with diverse suppliers ...

Repertoire Immune Medicines Inc. has entered into a collaboration and license agreement with Genentech Inc., a member of the Roche Group, to discover and develop innovative T cell-targeted immune ...

In this context, the Election Commission of Pakistan (ECP) again passed the buck on the federal government for lingering delay in the LG polls. Not attended by Chief Election Commissioner Sikandar ...

Genentech will pay $28 million upfront in the alliance, which could be worth up to $1 billion, to find medicines that target “new therapeutic intervention points across a range of diseases.” ...

Aviv Regev, executive vice president and head of Genentech Research & Early Development ... It would be the first obesity-targeted GLP-1 in pill form.

GameSpot may get a commission from retail offers. So, you've found your clients with specific preferences in Schedule 1 and want to know how to cater to them? We've got you covered with our full ...

It's a necessary investment. If you want to check out each property before ponying up the dough but can't quite find them, use the Schedule 1 property map above to find each one. Our list of the ...

Disclaimer: Schedule 1 is a fictional, satirical videogame, and the information in this guide relates only to the game. What is the complete list of Schedule 1 console commands and cheats?

Bay Area biotech giant Genentech is offering menopause support ... lost work time due to menopause symptoms is estimated to be $1.8 million a year. That price tag soared to $26.6 billion annually ...